Simvastatin reduces CCL2 expression in monocyte-derived cells by induction of a repressive CCL2 chromatin state
- 1 January 2014
- journal article
- Published by Elsevier in Human Immunology
- Vol. 75 (1) , 10-14
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Epigenetics in atherosclerosis and inflammationJournal of Cellular and Molecular Medicine, 2010
- Anti-inflammatory Agents: Present and FutureCell, 2010
- Immunomodulation by statins: mechanisms and potential impact on autoimmune diseasesArchivum Immunologiae et Therapiae Experimentalis, 2009
- Statins Control Oxidized LDL-Mediated Histone Modifications and Gene Expression in Cultured Human Endothelial CellsArteriosclerosis, Thrombosis, and Vascular Biology, 2009
- Statins Decrease the Aberrant HLA-DR Expression on Thyrocytes from Patients with Hashimoto's ThyroiditisHormone and Metabolic Research, 2008
- Immunomodulation by statins: Inhibition of cholesterol vs. isoprenoid biosynthesisBiomedicine & Pharmacotherapy, 2007
- Simvastatin affects cell motility and actin cytoskeleton distribution of microgliaGlia, 2005
- Statins Affect Cell-Surface Expression of Major Histocompatibility Complex Class II Molecules by Disrupting Cholesterol-Containing MicrodomainsHuman Immunology, 2005
- Statin Use Is Associated with Improved Function and Survival of Lung AllograftsAmerican Journal of Respiratory and Critical Care Medicine, 2003
- Translating the Histone CodeScience, 2001